Improving Clinical Trials In Psychiatric Health Care
An Interview With 2022 Rising Leader Kiri Granger
Kiri Granger, Monument Therapeutics’ chief scientific officer and executive director, and one of In Vivo’s 2022 Rising Leaders, hopes to take the company to the next level by rejecting the conventional one-size-fits-all approach to psychiatric clinical trials.
